Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Alvim

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|November 24, 2020
Developments in Vascular-Targeted Photodynamic Therapy for Urologic MalignanciesLucas Nogueira, Andrew T Tracey, Ricardo Alvim, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 13, 2021
A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomyRicardo Alvim, Amy Tin, Lucas Nogueira, et al.
Cancers|July 29, 2025
Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer ModelLucas Nogueira, Ricardo Alvim, Hanan Baker, et al.
Scientific Reports|March 2, 2021
Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancerBarak Rosenzweig, Renato B Corradi, Sadna Budhu, et al.
Oncoimmunology|May 10, 2019
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancerSouhil Lebdai, Mathieu Gigoux, Ricardo Alvim, et al.
European Urology Focus|June 23, 2019
Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer ModelRicardo Alvim, Karan Nagar, Sudeep Das, et al.
The Journal of Urology|October 9, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|January 8, 2020
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|March 19, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|November 24, 2020
Developments in Vascular-Targeted Photodynamic Therapy for Urologic MalignanciesLucas Nogueira, Andrew T Tracey, Ricardo Alvim, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|April 13, 2021
A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomyRicardo Alvim, Amy Tin, Lucas Nogueira, et al.
Cancers|July 29, 2025
Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer ModelLucas Nogueira, Ricardo Alvim, Hanan Baker, et al.
Scientific Reports|March 2, 2021
Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancerBarak Rosenzweig, Renato B Corradi, Sadna Budhu, et al.
Oncoimmunology|May 10, 2019
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancerSouhil Lebdai, Mathieu Gigoux, Ricardo Alvim, et al.
European Urology Focus|June 23, 2019
Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer ModelRicardo Alvim, Karan Nagar, Sudeep Das, et al.
The Journal of Urology|October 9, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|January 8, 2020
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|March 19, 2020
Reply by AuthorsSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
The Journal of Urology|December 24, 2019
Long-Term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center ExperienceSigrid Carlsson, Nicole Benfante, Ricardo Alvim, et al.
Pageof 2